Literature DB >> 7835395

The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye.

N N Osborne1, G Chidlow.   

Abstract

There is evidence in the literature to suggest that melatonin has a functional role in the iris-ciliary body (ICB). In this study we provide results which argue for the occurrence of melatonin receptors in this region of the eye. Autoradiography showed that specific binding of 125I-iodomelatonin is associated with the ICB although the resolution did not allow for discrimination of binding between the ciliary epithelium and the iris musculature. The binding of 125I-iodomelatonin to ICB homogenates is saturable with a single population of binding sites and with KD and Bmax values of 428 pM and 170 fmol (g wet weight)-1, respectively. The order of potency of various substances to compete with the 125I-iodomelatonin binding sites is chloromelatonin = melatonin > 6-OH-melatonin > N-acetylserotonin > 5-methoxytryptamine > serotonin. Neither iodomelatonin nor serotonin affected basal levels of cAMP, but both decreased the forskolin elevated cAMP levels. However, the iodomelatonin effect, unlike that of serotonin, was not antagonised by propranolol. The combined data argue for the presence of melatonin receptors in the ICB of the rabbit. These receptors are negatively linked to the stimulation of cAMP and are distinguishable from serotonin receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835395     DOI: 10.1006/exer.1994.1076

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  10 in total

Review 1.  Circadian organization of the mammalian retina: from gene regulation to physiology and diseases.

Authors:  Douglas G McMahon; P Michael Iuvone; Gianluca Tosini
Journal:  Prog Retin Eye Res       Date:  2013-12-12       Impact factor: 21.198

2.  Analogues of diverse structure are unable to differentiate native melatonin receptors in the chicken retina, sheep pars tuberalis and Xenopus melanophores.

Authors:  H Pickering; S Sword; S Vonhoff; R Jones; D Sugden
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse.

Authors:  Susana Alcantara-Contreras; Kenkichi Baba; Gianluca Tosini
Journal:  Neurosci Lett       Date:  2011-04-20       Impact factor: 3.046

4.  Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor.

Authors:  Jesus Pintor; Teresa Peláez; Charles H V Hoyle; Assumpta Peral
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 5.  Melatonin: an underappreciated player in retinal physiology and pathophysiology.

Authors:  Gianluca Tosini; Kenkichi Baba; Christopher K Hwang; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2012-08-31       Impact factor: 3.467

6.  Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells.

Authors:  Juanita Dortch-Carnes; Gianluca Tosini
Journal:  Exp Eye Res       Date:  2012-11-29       Impact factor: 3.467

Review 7.  Is the melatonin receptor type 1 involved in the pathogenesis of glaucoma?

Authors:  Gianluca Tosini; Michael Iuvone; Jeffrey H Boatright
Journal:  J Glaucoma       Date:  2013 Jun-Jul       Impact factor: 2.503

Review 8.  Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma.

Authors:  Alejandro Martínez-Águila; Alba Martín-Gil; Carlos Carpena-Torres; Cristina Pastrana; Gonzalo Carracedo
Journal:  Biomolecules       Date:  2021-02-24

9.  Changes in melatonin receptor expression in a murine model of glaucoma.

Authors:  Alejandro Martínez-Águila; Begoña Fonseca; María J Pérez de Lara; M Teresa Miras-Portugal; Rosa Gómez-Villafuertes; Gonzalo Carracedo; Jesús Pintor
Journal:  Mol Vis       Date:  2020-07-29       Impact factor: 2.367

Review 10.  Ocular Clocks: Adapting Mechanisms for Eye Functions and Health.

Authors:  Marie-Paule Felder-Schmittbuhl; Ethan D Buhr; Ouria Dkhissi-Benyahya; David Hicks; Stuart N Peirson; Christophe P Ribelayga; Cristina Sandu; Rainer Spessert; Gianluca Tosini
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.